Carol K. Kasper

4.7k total citations · 1 hit paper
103 papers, 3.7k citations indexed

About

Carol K. Kasper is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Carol K. Kasper has authored 103 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Hematology, 25 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Carol K. Kasper's work include Hemophilia Treatment and Research (81 papers), Blood Coagulation and Thrombosis Mechanisms (25 papers) and Chronic Myeloid Leukemia Treatments (21 papers). Carol K. Kasper is often cited by papers focused on Hemophilia Treatment and Research (81 papers), Blood Coagulation and Thrombosis Mechanisms (25 papers) and Chronic Myeloid Leukemia Treatments (21 papers). Carol K. Kasper collaborates with scholars based in United States, Italy and United Kingdom. Carol K. Kasper's co-authors include Louis M. Aledort, Peter H. Levine, Joseph C. Fratantoni, Sandor S. Shapiro, Jeanne M. Lusher, Jan van Eys, Jack Lazerson, Campbell W. McMillan, Samuel I. Rapaport and Stylianos E. Antonarakis and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Carol K. Kasper

97 papers receiving 3.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A More Uniform Measurement of Factor VIII Inhibitors

1975 513 citations Carol K. Kasper, Louis M. Aledort et al. Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol K. Kasper United States	32	3.0k	862	817	195	186	103	3.7k
G C White United States	26	2.0k 0.7×	462 0.5×	573 0.7×	177 0.9×	173 0.9×	51	2.7k
Dimitris Loukopoulos Greece	30	2.4k 0.8×	2.8k 3.3×	482 0.6×	117 0.6×	264 1.4×	134	3.7k
H Rochant France	26	978 0.3×	452 0.5×	604 0.7×	104 0.5×	192 1.0×	107	1.9k
Erik Hippe Denmark	25	1.5k 0.5×	347 0.4×	1.2k 1.4×	194 1.0×	128 0.7×	98	2.8k
Rosemary Biggs United Kingdom	30	2.1k 0.7×	632 0.7×	255 0.3×	254 1.3×	168 0.9×	74	2.7k
K Sawada Japan	25	1.1k 0.4×	571 0.7×	497 0.6×	124 0.6×	140 0.8×	60	2.4k
LL Sensenbrenner United States	24	1.2k 0.4×	426 0.5×	376 0.5×	113 0.6×	157 0.8×	67	2.0k
Rolf Rau Germany	23	963 0.3×	394 0.5×	405 0.5×	238 1.2×	163 0.9×	39	3.3k
Savita Rangarajan United Kingdom	29	1.9k 0.6×	438 0.5×	877 1.1×	140 0.7×	721 3.9×	102	3.0k
Ulf‐Henrik Mellqvist Sweden	24	1.4k 0.5×	439 0.5×	739 0.9×	129 0.7×	58 0.3×	60	2.2k

Countries citing papers authored by Carol K. Kasper

Since Specialization

Citations

This map shows the geographic impact of Carol K. Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol K. Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol K. Kasper more than expected).

Fields of papers citing papers by Carol K. Kasper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol K. Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol K. Kasper. The network helps show where Carol K. Kasper may publish in the future.

Co-authorship network of co-authors of Carol K. Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of Carol K. Kasper. A scholar is included among the top collaborators of Carol K. Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol K. Kasper. Carol K. Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kasper, Carol K.. (2012). Judith Graham Pool and the discovery of cryoprecipitate. Haemophilia. 18(6). 833–835. 24 indexed citations

Viel, Kevin R., Afshin Ameri, Thomas C. Abshire, et al.. (2009). Inhibitors of Factor VIII in Black Patients with Hemophilia. New England Journal of Medicine. 360(16). 1618–1627. 134 indexed citations

Kasper, Carol K. & Julie Lin. (2006). Prevalence of sporadic and familial haemophilia. Haemophilia. 13(1). 90–92. 51 indexed citations

Li, Xuemin, William A. Scaringe, Kathleen A. Hill, et al.. (2001). Frequency of recent retrotransposition events in the human factor IX gene. Human Mutation. 17(6). 511–519. 55 indexed citations

Li, Xuemin, Joni B. Drost, Stacy Roberts, Carol K. Kasper, & Steve S. Sommer. (2000). Factor IX mutations in South Africans and African Americans are compatible with primarily endogenous influences upon recent germline mutations. Human Mutation. 16(4). 371–371. 13 indexed citations

Kasper, Carol K.. (1999). Human Factor VIII for Bleeding in Patients with Inhibitors. Vox Sanguinis. 77(S1). 47–48.

Kasper, Carol K.. (1995). In vivo recovery and early half‐life of infused factor VIII in haemophilia A. Haemophilia. 1(1). 14–16. 4 indexed citations

Mosley, James W., Marek Nowicki, Carol K. Kasper, et al.. (1994). Hepatitis A Virus Transmissionby Blood Products in theUnited States. Vox Sanguinis. 67(1). 24–28. 1 indexed citations

Addiego, Joseph E., Carol K. Kasper, C F Abildgaard, et al.. (1993). Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. The Lancet. 342(8869). 462–464. 136 indexed citations

10.

Lefkowitz, Jerry B., Dougald M. Monroe, Carol K. Kasper, & Harold R. Roberts. (1993). Comparison of the behavior of normal factor IX and the factor IX BM variant hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources. American Journal of Hematology. 43(3). 177–182. 5 indexed citations

11.

Kasper, Carol K.. (1991). Complications of Hemophilia A Treatment: Factor VIII Inhibitorsa. Annals of the New York Academy of Sciences. 614(1). 97–105. 17 indexed citations

12.

Kasper, Carol K., Pier Mannuccio Mannucci, Doreen B. Brettler, et al.. (1991). Haemophilia in the 1990s: Report of a Joint Meeting of the World Health Organization and World Federation of Hemophilia. Vox Sanguinis. 61(3). 221–224. 6 indexed citations

13.

Kasper, Carol K., Hugh C. Kim, Edward D. Gomperts, et al.. (1991). In Vivo Recovery and Survival of Monoclonal-Antibody-Purified Factor VIII Concentrates. Thrombosis and Haemostasis. 66(6). 730–733. 14 indexed citations

14.

Østerud, Bjarne, Carol K. Kasper, & Christina Prodanos. (1979). Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules. Thrombosis Research. 15(1-2). 235–243. 7 indexed citations

15.

Kasper, Carol K., Bjarne Østerud, & Samuel I. Rapaport. (1977). Hemophilia B: Genetic Variants and Carrier Detection. Thrombosis and Haemostasis. 2 indexed citations

16.

Kasper, Carol K., et al.. (1975). Determinants of Factor VIII Recovery in Cryoprecipitate. Transfusion. 15(4). 312–322. 33 indexed citations

17.

Kasper, Carol K. & J. David McDonald. (1973). Standardization of Factor VIII Preparations. New England Journal of Medicine. 288(4). 215–215. 9 indexed citations

18.

Kasper, Carol K., et al.. (1972). Bleeding Times and Platelet Aggregation After Analgesics in Hemophilia. Annals of Internal Medicine. 77(2). 189–193. 28 indexed citations

19.

Feinstein, Donald I., et al.. (1969). Hemophilia A: Polymorphism Detectable by a Factor VIII Antibody. Science. 163(3871). 1071–1072. 59 indexed citations

20.

Kasper, Carol K. & Ralph O. Wallerstein. (1966). Red Cell Values in Healthy Adolescents. American Journal of Clinical Nutrition. 18(4). 286–293. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact